Lantheus (LNTH) Stock: Buy, Sell, or Hold?
LNTH - Lantheus Holdings, Inc
$100.24
-0.15 (-0.15%)
▼
5d:
+0.24%
30d:
+0.24%
90d:
-3.36%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When LNTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: LNTH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: LNTH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$154.09
Based on 11.5% avg growth
INTRINSIC VALUE TODAY
$95.68
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LNTH is currently trading at $100.24, which is considered slightly high relative to its 30-day fair value range of $99.74 to $100.40. From a valuation perspective, the stock is trading at a premium (Forward PE: 15.7) compared to its historical average (14.1). At these levels, the market is pricing in 3.6% annual earnings growth.
Technical Outlook: Technically, LNTH is in a strong downtrend. The price is currently testing key support at $99.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LNTH scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LNTH is in a strong downtrend. The price is currently testing key support at $99.59. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: LNTH scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$99.74 -
$100.40
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($106.99)
- BULLISH: Expecting earnings turnaround to 3.6% growth with 2.7% revenue growth
- BULLISH: Bottoming setup score 75/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$99.74 -
$100.40
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$99.60
Resistance Level
$100.46
Current Trend
Strong Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.72
Wall Street Target
$106.99
(+6.7%)
Revenue Growth (YoY)
2.7%
Earnings Growth (YoY)
-0.9%
Profit Margin
17.7%
Valuation Premium vs History
+3.6% premium
PE vs Historical
15.7 vs 14.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.6%
(market-implied from PE analysis)
1-Year Target
$103.85
(+4%)
2-Year Target
$107.59
(+7%)
3-Year Target
$111.46
(+11%)
3-Yr Target (if PE normalizes)
(PE: 16→14)
PE COMPRESSION
$99.99
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 19.0%)
$213.39
(+113%)
Base:
(SPY PE: 15.7, Growth: 19.0%)
$168.89
(+69%)
Bear:
(PE: 13.4, Growth: 19.0%)
$143.56
(+43%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 24.31 | Current EPS (TTM): $4.13
Bull Case
$170.52
(+70%)
Analyst growth 54.4%, PE expands to 26.7
Base Case
$155.02
(+55%)
Market implied 54.4%, PE stable at 24.3
Bear Case
$68.27
(-32%)
Severe decline -20.0%, PE contracts to 20.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 22, 2026 8:11 AM ET
Data refreshes hourly during market hours. Next update: 9:11 AM
Data refreshes hourly during market hours. Next update: 9:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LNTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
29 analysts |
$207 | 59 HOLD |
|
ELAN
Elanco Animal Health |
STRONG BUY
16 analysts |
$31 | 50 HOLD |
|
ALKS
Alkermes Plc |
STRONG BUY
19 analysts |
$56 | 47 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 67 BUY |
|
HROW
Harrow Health Inc |
STRONG BUY
9 analysts |
$65 | 61 BUY |
Advanced LNTH Option Strategies
Professional options setups generated by AI based on today's LNTH price and gamma walls.
